Description
Rebuttal to ‘The COMPARZ study presented at ESMO 2012: how pliable is non-inferiority?’
Article: Rebuttal to ‘The COMPARZ study presented at ESMO 2012: how pliable is non-inferiority?’
€3.03
Related products
-
Article: Highlights in gynaecological cancers
€3.03 Add to cart -
Article: Highlights in digestive oncology
€3.03 Add to cart -
Article: Calendar of events
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart
